Early statin therapy for acute coronary syndromes (Q34979669)

5 August 2017

1 reference

title

Early statin therapy for acute coronary syndromes (English)

1 reference

5 August 2017

1 reference

acute coronary syndrome

1 reference

1

Simon De Denus

1 reference

5 August 2017

Sarah A Spinler

2

1 reference

PubMed ID

12398573

5 August 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

Annals of Pharmacotherapy

5 August 2017

1 reference

5 August 2017

36

1 reference

5 August 2017

11

1 reference

5 August 2017

1749-1758

1 reference

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

5 August 2017

1 reference

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

21 January 2018

1 reference

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

21 January 2018

1 reference

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

Established and emerging cardiovascular risk factors

21 January 2018

1 reference

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

The comparative pathobiology of atherosclerosis and restenosis

21 January 2018

1 reference

Cellular adhesion molecules on vascular smooth muscle cells

21 January 2018

1 reference

Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms.

21 January 2018

1 reference

Strategies to achieve coronary arterial plaque stabilization

21 January 2018

1 reference

Role of plaque rupture in acute coronary syndromes

21 January 2018

1 reference

Pathophysiology and clinical significance of atherosclerotic plaque rupture

21 January 2018

1 reference

Beneficial effects of statins in coronary artery disease--beyond lowering cholesterol

21 January 2018

1 reference

Rapid improvement of nitric oxide bioavailability after lipid-lowering therapy with cerivastatin within two weeks.

21 January 2018

1 reference

Cerivastatin, a hydroxymethylglutaryl coenzyme a reductase inhibitor, improves endothelial function in elderly diabetic patients within 3 days

21 January 2018

1 reference

Rapid effects on vascular function after initiation and withdrawal of atorvastatin in healthy, normocholesterolemic men.

21 January 2018

1 reference

Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation

21 January 2018

1 reference

Simvastatin preserves coronary endothelial function in hypercholesterolemia in the absence of lipid lowering

21 January 2018

1 reference

Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease. A potential noninvasive marker of healing coronary endothelium

21 January 2018

1 reference

Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization

21 January 2018

1 reference

Influence of pravastatin on lipoproteins, and on endothelial, platelet, and inflammatory markers in subjects with peripheral artery disease

21 January 2018

1 reference

An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro

21 January 2018

1 reference

Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.

21 January 2018

1 reference

Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels

21 January 2018

1 reference

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

21 January 2018

1 reference

Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease.

21 January 2018

1 reference

Guide to anticoagulant therapy: Heparin : a statement for healthcare professionals from the American Heart Association

21 January 2018

1 reference

Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V, and factor XIII and by enhancing factor Va inactivation

21 January 2018

1 reference

Antiatherothrombotic properties of statins: implications for cardiovascular event reduction.

21 January 2018

1 reference

Do HMG-CoA reductase inhibitors affect fibrinogen?

21 January 2018

1 reference

Pravastatin restored the infarct size-limiting effect of ischemic preconditioning blunted by hypercholesterolemia in the rabbit model of myocardial infarction

21 January 2018

1 reference

Improvement of left ventricular remodeling and function by hydroxymethylglutaryl coenzyme a reductase inhibition with cerivastatin in rats with heart failure after myocardial infarction

21 January 2018

1 reference

Benefits of immediate initiation of statin therapy following successful coronary stent implantation in patients with stable and unstable angina pectoris and Q-wave acute myocardial infarction

21 January 2018

1 reference

Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study

21 January 2018

1 reference

Withdrawal of statins increases event rates in patients with acute coronary syndromes

21 January 2018

1 reference

Lack of association of lipoprotein(a) levels with coronary calcium deposits in asymptomatic postmenopausal women

21 January 2018

1 reference

Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes

21 January 2018

1 reference

A Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary Syndromes

21 January 2018

1 reference

A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina

21 January 2018

1 reference

Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial

21 January 2018

1 reference

Randomized trial of aspirin, sibrafiban, or both for secondary prevention after acute coronary syndromes

21 January 2018

1 reference

Rationale and design of the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study that evaluates atorvastatin in unstable angina pectoris and in non-Q-wave acute myocardial infarction

21 January 2018

1 reference

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

21 January 2018

1 reference

Ongoing clinical trials of statins

21 January 2018

1 reference

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban

21 January 2018

1 reference

Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators.

21 January 2018

1 reference

Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial

21 January 2018

1 reference

What is the role of intensive cholesterol lowering in the treatment of acute coronary syndromes?

21 January 2018

1 reference

Usefulness of in-hospital prescription of statin agents after angiographic diagnosis of coronary artery disease in improving continued compliance and reduced mortality

21 January 2018

1 reference

Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1A413

1 reference

5 August 2017

1 reference

PubMed ID

12398573